These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 4565942)
41. Ly-4, a new locus determining a lymphocyte cell-surface alloantigen in mice. Snell GD; Cherry M; McKenzie IF; Bailey DW Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1108-11. PubMed ID: 4515607 [TBL] [Abstract][Full Text] [Related]
42. The genetic control of the immune response to different antigenic determinants within the synthetic polypeptide poly(His, Glu)-polyPro-polyLys. Mozes E; Shaltiel S; Sela M Eur J Immunol; 1974 Jul; 4(7):463-7. PubMed ID: 4137977 [No Abstract] [Full Text] [Related]
43. Diseases of autoimmunity. Dixon FJ Natl Cancer Inst Monogr; 1982; 60():181-92. PubMed ID: 6214718 [No Abstract] [Full Text] [Related]
44. [Inactivation of allogeneic stem cells by lymphocytes identical as regards the H2 system of tissue compatibility]. Petrov RV; Egorov IK; Seslavina LS; Panteleev EI; Egorova OS Dokl Akad Nauk SSSR; 1974; 219(6):1489-91. PubMed ID: 4155671 [No Abstract] [Full Text] [Related]
45. [Autoreactivity and autoaggression]. Wekerle H Internist (Berl); 1979 Oct; 20(10):459-64. PubMed ID: 92463 [No Abstract] [Full Text] [Related]
48. Self-tolerance and autoimmunity in the thyroid. Allison AC N Engl J Med; 1976 Oct; 295(15):821-7. PubMed ID: 183115 [No Abstract] [Full Text] [Related]
49. Cross-reactivity between HL-A and H-2 antigens. II. Allogeneic sensitization by xenogeneic soluble lymphocyte antigens (HL-A). Götze BD; Lee S; Ferrone S; Pellegrino MA; Reisfeld RA Transplant Proc; 1973 Mar; 5(1):467-70. PubMed ID: 4572106 [No Abstract] [Full Text] [Related]
50. [Modern problems of immunogenetics]. Petrov RV Vestn Akad Med Nauk SSSR; 1973; 28(1):81-90. PubMed ID: 4589094 [No Abstract] [Full Text] [Related]
52. [Autoimmunization as a pathogenetic principle]. Scheiffarth F; Warnatz H Internist (Berl); 1970 Jan; 11(1):1-5. PubMed ID: 4939365 [No Abstract] [Full Text] [Related]
53. Preparation and properties of rabbit anti-mouse plasmacyte serum purified by in vivo absorption: further evidence for a new antigenic determinant on plasmacytes. Yutoku M; Grossberg AL; Pressman D J Immunol; 1974 Mar; 112(3):911-8. PubMed ID: 4130115 [No Abstract] [Full Text] [Related]
54. Immunofluorescence studies on thymocytotoxic antibody from New Zealand Black mice. Parker LM; Chused TM; Steinberg AD J Immunol; 1974 Jan; 112(1):285-92. PubMed ID: 4590823 [No Abstract] [Full Text] [Related]
56. The take-home lesson--1971. Cohn M Ann N Y Acad Sci; 1971 Dec; 190():529-84. PubMed ID: 4109646 [No Abstract] [Full Text] [Related]
57. Selective immunosuppression by drugs in balanced immune responses. Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113 [No Abstract] [Full Text] [Related]
58. Mouse bone marrow lymphocytes and their differentiation. Ryser JE; Vassalli P J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258 [No Abstract] [Full Text] [Related]
59. [Contemporary views on the pathogenesis of atherosclerosis]. Nagornev VA; Voskan'iants AN Vestn Ross Akad Med Nauk; 2006; (9-10):66-74. PubMed ID: 17111928 [TBL] [Abstract][Full Text] [Related]
60. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Sjögren HO; Hellström I; Bansal SC; Hellström KE Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1372-5. PubMed ID: 5288389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]